Effects of inhaled low molecular weight heparin on airway allergic inflammation in aerosol-ovalbumin-sensitized guinea pigs

Japanese Journal of Pharmacology

Volumn 82, Issue 4, 2000, Pages 326-330

  Wang, Qing Li ^b   Shang, Xue Yuan ^c   Zhang, Shi Ling ^a   Ji, Jian Bo ^a   Cheng, Yan Na ^a   Meng, Ya Juan ^a   Zhu, Ye Jing ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c NATL INST BIOSCI HUM TECHNOL   (Japan)

Author keywords

Airway allergic inflammation; Bronchial asthma; Bronchoalveolar lavage fluid; Eosinophil; Low molecular weight heparin (LMWH)

Indexed keywords

DEXAMETHASONE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; EOSINOPHIL; GUINEA PIG; NONHUMAN; RESPIRATORY TRACT INFLAMMATION;

EID: 0034071286     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.326     Document Type: Article

References (23)

1. Schwartz LB and Bradford TR: Regulation of tryptase from human lung mast cells by heparin. J Biol Chem 261, 7372-7379 (1986)
2. Naclerio RM and Baroody F: Understanding the inflammatory processes in upper allergic airway disease and asthma. J Allergy Clin Immunol 101, s345-s351 (1998)
3. Garg HG, Joseph PA, Yoshida K, Thompson BT and Hales CA: Antiproliferative role of 3-O-sulfate glucosamine in heparin on cultured pulmonary artery smooth muscle cells. Biochem Biophys Res Commun 224, 468-473 (1996)
4. Shao NS, Wang HX, Zhou TC, Xue YN and Liu C: Heparin potentiation of the effect of acidic fibroblast growth factor on asrtocytes and neurons. Life Sci 54, 785-789 (1994)
5. Lagodzinski Z, Gorski A and Waski M: Immunosuppressive action of low-dose heparin: Effect on skin allograft survival. Transplantation 50, 714-715 (1990)
6. Rusnati M, Coltrini D, Oresta P, Zoppetti G, Albini A, Noonan D, Fagagna F, Giacca M and Presta M: Interaction of HIV Tat protein with heparin: Role of the backbone structure, sulfation and size. J Biol Chem 212, 11313-11320 (1997)
7. Jaques LB: Heparins anionaic polyelectrolyte drugs. Pharmacol Rev 337, 717-720 (1979)
8. Polosa R, Magri S, Vanchari C, Armato F, Santonacito G, Mistretta A and Crimi N: Time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled heparin in allergic asthma. J Allergy Clin Immunol 99, 338-344 (1997)
9. Ming L, Zhang Y, Li W, Wang Y and Xu SY: Antiasthmatic effect of heparin. Chin Pharmacol Bul 13, 361-364 (1997)
10. Ahmed T, Campo C, Abraham MK, Molinari JF, Abraham WM, Askin D, Syriste T, Andersson LO and Svahn CM: Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin comparison with a low molecular weight heparin. Am J Respir Cirt Care Med 155, 1848-1855 (1997)
11. Wang CZ, Wang CX, Qian GS and Guo XJ: Modulation of platelet-activiting factor antagonist BN 52021 on hypodense eosinophils in airway of allergic guinea pigs. Chin Pharmacol Bull 12, 238-240 (1996)
12. Wang CZ, Pu Y, Wu GM, Li SP and Guo XJ: Inhalation of platelet-activating factor induced guiea pigs airway hyperresponsiveness: Role of eosinopils activation. Chin J Tubcul and Respir Dis 18, 155-157 (1995)
13. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF and Barnes PJ: Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 142, 3518-3526 (1989)
14. Strath M, Warren DJ and Sanderson CJ: Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 83, 209-215 (1985)
15. Xiang JJ and Chen HC: Modified method of fluorometric determination of blood histamine. Acta Acad Med Sin 3, 183-186 (1981)
16. Cottin V, Deviller P, Tardy F and Cordier JF: Urinary eosinophil-derived neurotoxion/protein X: A simple method for assessing eosinophil dagranulation in vivo. J Allergy Clin Immunol 101, 116-123 (1998)
17. Ahmed T, Syriste T, Mendelssohn R, Sorace D, Mansour E, Lansing M, Abraham WM and Robinson MJ: Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation? J Appl Physiol 74, 893-901 (1993)
18. Wang QL, Shang XY and Zhang SL: Anti-allergic effects of low molecular weight heparin. J Chin Pharm Sci 8, 163-166 (1999)
19. Somlyo AV, Bond M, Somlyo AP and Scarpa A: Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle. Proc Natl Acad Sci USA 82, 5231-5235 (1985)
20. Kobayashi S, Somlyo AV and Somlyo AP: Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem Biophys Res Commun 153, 625-631 (1988)
21. Lucio J, D'brot J, Guo CB, Abraham WM, Lichtenstein LM, Sobotka AK and Ahmed T: Immunologic mast cell-mediated response and histamine release are attenuated by heparin. J Appl Physiol 73, 1093-1101 (1992)
22. Burrows B, Hansan FM and Barbee RA: Epidemiologic observations on eosinophilia and its relation to respiratory disorders. Am Rev Respir Dis 122, 709-715 (1980)
23. Weller PF: Updates on cells and cytokines: Human eosinophils. J Allergy Clin Immnuol 100, 283-287 (1997)